Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

2.67
-0.0900-3.26%
Post-market: 2.710.0400+1.50%18:46 EDT
Volume:11.26K
Turnover:30.24K
Market Cap:3.69M
PE:-0.13
High:2.78
Open:2.75
Low:2.63
Close:2.76
52wk High:34.60
52wk Low:2.61
Shares:1.38M
Float Shares:1.25M
Volume Ratio:0.16
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.2000
EPS(LYR):-31.6731
ROE:-241.14%
ROA:-118.81%
PB:1.22
PE(LYR):-0.08

Loading ...

BioRestorative Therapies VP of R&D Silva Resigns, Seeks About $1.29 Million Severance

Reuters
·
Yesterday

BioRestorative Therapies Inc Expected to Post a Loss of $2.50 a Share - Earnings Preview

Reuters
·
Yesterday

BioRestorative Amends 8-K to Clarify Auditor Change, Audit Committee Probe Scope

Reuters
·
Yesterday

BioRestorative Therapies Inc trading halted, news pending

TIPRANKS
·
Sep 05

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Sep 04

BioRestorative Therapies announces 1-for-20 reverse stock split

TIPRANKS
·
Sep 03

Biorestorative Therapies Announces Reverse Stock Split

Reuters
·
Sep 03

BioRestorative Therapies Announces Reverse Stock Split

THOMSON REUTERS
·
Sep 03

BioRestorative Therapies - Appoints Steven Brown as Chairman of the Board Effective September 1, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies - Katharyn Field Steps Aside as Interim CEO and CFO Effective August 26, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Inc: Appoints Anna Skowron as Chief Financial Officer, Effective August 27, 2026

THOMSON REUTERS
·
Sep 02

BioRestorative Therapies Switches Auditor to Bush & Associates CPA, Dismisses CBIZ CPAs

Reuters
·
Sep 02

BioRestorative Therapies Gets NASDAQ Notice over Late Filing of Quarterly Report

Reuters
·
Aug 26

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 19

BioRestorative Therapies Delays Q2 10-Q Filing After CEO, CFO Resignations

Reuters
·
Aug 15

BioRestorative Therapies: Has not Made Decision to Discontinue Suspended Product Lines - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Conducting Review of the Documentation, Sourcing, Regulatory Status Associated with Suspended Products- SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies: Suspends All Orders, Shipments of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, on Aug 7 - SEC Filing

THOMSON REUTERS
·
Aug 15

BioRestorative Therapies Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioRestorative Therapies Director Esha Randhawa Files Initial Beneficial Ownership Statement

Reuters
·
Jul 31